Literature DB >> 24426424

Liver transplantatation- an overview.

Rakesh Rai1.   

Abstract

Liver transplantation is a therapeutic option of choice for acute and chronic end-stage liver disease. Indications, contraindications, and surgical procedures for the liver transplantation have become well established. In most part of the world, the main source of liver for transplantation remains the donation after brain death (DBD), but in view of increasing death on the waiting list due to shortage of brain dead organs other options such as split liver transplantation, living donor liver transplantation (LDLT), and donation after cardiac death (DCD) have been used. In the pretransplantation era, liver failure was nearly universally fatal, with mortality from fulminant hepatic failure of 80-90 %, and 1-year mortality in decompensated cirrhosis of more than 50 %. In contrast, liver transplantation patient survival is presently more than 85 % at 1 year and more than 70 % at 5 years, emphasizing the clinical benefit of liver transplantation for either acute or chronic liver failure.

Entities:  

Keywords:  End-stage liver disease; Liver transplantation; Living donor

Year:  2012        PMID: 24426424      PMCID: PMC3689386          DOI: 10.1007/s12262-012-0643-0

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  17 in total

Review 1.  How to prevent and manage biliary complications in living donor liver transplantation?

Authors:  Satoru Todo; Hiroyuki Furukawa; Toshiya Kamiyama
Journal:  J Hepatol       Date:  2005-07       Impact factor: 25.083

Review 2.  Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.

Authors:  Anna L Taylor; Christopher J E Watson; J Andrew Bradley
Journal:  Crit Rev Oncol Hematol       Date:  2005-10       Impact factor: 6.312

3.  Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease.

Authors:  Robert Pfitzmann; Jeannette Schwenzer; Nada Rayes; Daniel Seehofer; Ruth Neuhaus; Natascha C Nüssler
Journal:  Liver Transpl       Date:  2007-02       Impact factor: 5.799

Review 4.  Fulminant and subfulminant liver failure: definitions and causes.

Authors:  J Bernuau; B Rueff; J P Benhamou
Journal:  Semin Liver Dis       Date:  1986-05       Impact factor: 6.115

5.  Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants.

Authors:  C E Broelsch; J C Emond; P F Whitington; J R Thistlethwaite; A L Baker; J L Lichtor
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

6.  Treatment of primary liver graft nonfunction with prostaglandin E1.

Authors:  P D Greig; G M Woolf; S B Sinclair; M Abecassis; S M Strasberg; B R Taylor; L M Blendis; R A Superina; M F Glynn; B Langer
Journal:  Transplantation       Date:  1989-09       Impact factor: 4.939

7.  Piggy-back versus conventional technique in liver transplantation: report of a randomized trial.

Authors:  E Jovine; A Mazziotti; G L Grazi; G Ercolani; M Masetti; M Morganti; F Pierangeli; B Begliomini; P G Mazzetti; R Rossi; R Paladini; A Cavallari
Journal:  Transpl Int       Date:  1997       Impact factor: 3.782

8.  Split-liver transplantation: a comparison of ex vivo and in situ techniques.

Authors:  J Reyes; D Gerber; G V Mazariegos; A Casavilla; R Sindhi; J Bueno; J Madariaga; J J Fung
Journal:  J Pediatr Surg       Date:  2000-02       Impact factor: 2.545

Review 9.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

10.  Vascular complications after orthotopic liver transplantation.

Authors:  A N Langnas; W Marujo; R J Stratta; R P Wood; B W Shaw
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

View more
  4 in total

1.  Intereukin-10 and Kupffer cells protect steatotic mice livers from ischemia-reperfusion injury.

Authors:  Alton G Sutter; Arun P Palanisamy; Justin D Ellet; Michael G Schmidt; Rick G Schnellmann; Kenneth D Chavin
Journal:  Eur Cytokine Netw       Date:  2014 Oct-Dec       Impact factor: 2.737

2.  In Vitro Generation of Functional Liver Organoid-Like Structures Using Adult Human Cells.

Authors:  Sarada Devi Ramachandran; Katharina Schirmer; Bernhard Münst; Stefan Heinz; Shahrouz Ghafoory; Stefan Wölfl; Katja Simon-Keller; Alexander Marx; Cristina Ionica Øie; Matthias P Ebert; Heike Walles; Joris Braspenning; Katja Breitkopf-Heinlein
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

3.  Anesthesia Management of Modified Ex Vivo Liver Resection and Autotransplantation.

Authors:  Fujun Cheng; Zhiyong Yang; Jing Zeng; Jianteng Gu; Jian Cui; Jiaoning Ning; Bin Yi
Journal:  Ann Transplant       Date:  2018-04-27       Impact factor: 1.530

Review 4.  Domino Hepatocyte Transplantation: A Therapeutic Alternative for the Treatment of Acute Liver Failure.

Authors:  Liana Monteiro da Fonseca Cardoso; Lucio Filgueiras Pacheco Moreira; Marcelo Alves Pinto; Andrea Henriques-Pons; Luiz Anastácio Alves
Journal:  Can J Gastroenterol Hepatol       Date:  2018-07-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.